COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

Covid-19 booster jabs will be limited to people over 65 or those at higher risk of serious illness, under new US government rules.

The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...